GPR54 is a Gq‐protein coupled receptor involved in cancer metastasis and regulation of the endocrine system. GPR54 activation by endogenous ligands attenuates the mobility of carcinomas and stimulates the secretion of gonadotropin‐releasing hormone. GPR54 agonists are, therefore, potential therapeutic candidates for cancer metastasis and hormonal diseases. Pentapeptide derivatives of kisspeptin C‐terminus were identified as potent GPR54 agonists in our previous studies. In the present study, we investigated the structure‐activity relationship of a variety of pentapeptides having various fluorine‐substituted benzoyl groups at the N‐terminus. Among these, a 4‐fluorobenzoyl derivative was the most potent agonist. On the other hand, the derivatives having multiple fluoro‐substituting groups showed less binding affinity. NMR analysis of these peptides and their N‐terminal partial structures suggested that fluorine substituents affect the benzoyl conformation. o‐Monofluorobenzoyl is likely to be in a coplanar conformation due to the intramolecular CFHN hydrogen bonding between o‐fluorine and amide hydrogen; the o,o‐difluorobenzoyl moiety exists in a distorted conformation probably due to the steric hindrance and/or electrostatic repulsion between two o‐fluorine atoms and carbonyl oxygen. © 2008 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 90: 503–511, 2008. This article was originally published online as an accepted preprint. The “Published Online” date corresponds to the preprint version. You can request a copy of the preprint by emailing the Biopolymers editorial office at biopolymers@wiley.com
No takes yet. Share an insight, caveat, or question.
Tomita et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: